您的位置:易推广 > 生物试剂/抗体/细胞 > 生物制剂 > 克隆系统 > 上海凯博生物科技有限公司(武汉分公司) > 产品展示 > 抗体 > *新抗体 > Anti-AKAP12/Gravin丝氨酸抑制蛋白激酶C底物抗体

产品展示

Anti-AKAP12/Gravin丝氨酸抑制蛋白激酶C底物抗体

点击次数:260发布时间:2012/12/26 3:47:54

Anti-AKAP12/Gravin丝氨酸抑制蛋白激酶C底物抗体

更新日期:2024/9/5 14:43:27

所 在 地:其它

产品型号:BY-1381R

简单介绍:本公司经销AKAP12/Gravin,丝氨酸抑制蛋白激酶C底物抗体,克隆类型为polyclonal,宿主来源是Rabbit,AKAP12/Gravin丝氨酸抑制蛋白激酶C底物抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

优质供应

详细内容

本公司经销AKAP12/Gravin,丝氨酸抑制蛋白激酶C底物抗体,克隆类型为polyclonal,宿主来源是Rabbit,AKAP12/Gravin丝氨酸抑制蛋白激酶C底物抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

货号:BY-1381R
英文名称:Anti-AKAP12/Gravin
中文名称:丝氨酸抑制蛋白激酶C底物抗体
其他名称:A kinase (PRKA) anchor protein (gravin) 12; A kinase Anchor Protein 12; A kinase anchor protein 250kDa; AKAP 12; AKAP 250; AKAP250; DKFZp686M0430; DKFZp686O0331; Gercelin; Gravin; Kinase scaffold protein gravin; Myasthenia gravis autoantigen gravin; Srcs5; SSeCKS; Tsga12.
抗体来源:Rabbit
克隆类型:polyclonal
蛋白分子量:predicted molecular weight: 185kDa
纯化方法:affinity purified by Protein A
交叉反应:hu, mo, rat, dog
产品介绍:Gravin (also known as A Kinase Anchor Protein 12, AKAP12) was cloned from a cDNA expression library screened with serum, from a myasthenia gravis patient. Antibodies to Gravin were found in 22 out of 72 myasthemia gravis patients and absent in sera of normal individuals. This protein is a myristoylated high molecular weight cytoplasmic protein expressed in endothelial cells, cultured fibroblasts and osteosarcoma cells and highly expressed in the brain. Gravin can bind kinases like PKA and PKC by different domains of the protein and can localize these kinases to specific domains in the cell. Upon differentiation of NT2 cells to neurons (NT2 N), Gravin expression is up regulated and enriched at the inner peripheral cortex in close proximity to the plasma membrane. In differentiated cells, gravin is co-localized with PKCbII, PKCa and PKA. Decreased binding of PKCa to gravin was found after activation of PKC.

联系我们

联系人:王羽

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【未认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:生产商
  • 注册资金:人民币**万

script>
在线咨询

提交